Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

The OraGrowtH Phase 3 Trial is a multi-national trial. The goals of the trial are to study LUM-201 as a treatment for Pediatric Growth Hormone Deficiency (PGHD) in naive to treatment children and validate the LUM-201 predictive enrichment marker (LUM-201 PEM) strategy to select subjects likely to respond to therapy with daily oral LUM-201.

Participants needed: 150
Trial details
Phase: Phase 3Age: 3-11Biological sex: AllType: InterventionalSponsor: Lumos PharmaUpdated: Jul 2, 2026Locations: 37
Eligibility criteria

Subjects must be naïve to treatment and prepubertal [+9]

Any medical or genetic condition which, in the opinion of the Investigator or Me... [+16]

Read more
Status: Not yet recruiting

Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency

This is a Multi-national Trial. The Goal of the Trial is to Offer Subjects Who Complete 12 Months in the LUM-201-10 Phase 3 Trial up to an Additional 36 Months of Treatment of LUM-201 While Evaluating Safety and Tolerability of LUM-201.

Participants needed: 150
Trial details
Phase: Phase 3Age: 4-12Biological sex: AllType: InterventionalSponsor: Lumos PharmaUpdated: Aug 19, 2025
Eligibility criteria

Parent/caregiver must be willing to provide written informed consent, and the su... [+3]

Subject has a medical or genetic condition that, in the opinion of the Investiga... [+2]

Read more